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Accepted 4 September 2015; Published online 5 September 2015AbstractBackground: The promotion of health equity, the absence of avoidable and unfair differences in health outcomes, is a global
imperative. Systematic reviews are an important source of evidence for health decision makers but have been found to lack assessments
of the intervention effects on health equity. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) is a
27-item checklist intended to improve transparency and reporting of systematic reviews. We developed an equity extension for PRISMA
(PRISMA-E 2012) to help systematic reviewers identify, extract, and synthesize evidence on equity in systematic reviews.
Methods and Findings: In this explanation and elaboration article, we provide the rationale for each extension item. These items are
additions or modifications to the existing PRISMA statement items, to incorporate a focus on equity. An example of good reporting is
provided for each item as well as the original PRISMA item.
Conclusions: This explanation and elaboration document is intended to accompany the PRISMA-E 2012 statement and the PRISMA
statement to improve understanding of the reporting guideline for users. The PRISMA-E 2012 reporting guideline is intended to improve
transparency and completeness of reporting of equity-focused systematic reviews. Improved reporting can lead to better judgment of
applicability by policy makers which may result in more appropriate policies and programs and may contribute to reductions in health
inequities.  2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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4.0/).1. Introduction
Promoting health equity and reducing avoidable health in-
equalities is a global imperative, endorsed by the Rio Summit
inBrazil in 2011, the PanAmericanHealthOrganization, and
theWorldHealthOrganization [1e3]. Health inequalities are
differences in health outcomes across individuals in a
population or between different population groups, whereas
health inequities are inequalities which are avoidable and
unfair [4,5]. Inequities are not only due to poverty, but may
also be due to unfair differences in health across other
characteristics such as sex/gender, geography, and ethnicity
[6]. The concept of health equity also suggests that groupss article under the CC BY license (http://creativecommons.org/licenses/by/
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to factors such as discrimination or inadequate access. In this
reporting guideline, we focus on unfair inequalities in health
outcomes and therefore use the term ‘‘equity.’’
Systematic reviews are recognized as an important
source of rigorously and transparently synthesized informa-
tion by health decision makers [2,7e9]. Health decision
makers have described lack of evidence on equity as a
barrier to using systematic reviews and guidelines [5,10],
and arguably, primary studies themselves. However, a
2010 systematic review found that there is a lack of detail
in reporting of certain aspects important to health equity
including population characteristics, assessment of
credibility of subgroup analyses, and judgment about the
applicability of the findings to other settings with fewer
than half of the included reviews reporting on socio-
demographic characteristics (such as age, sex, place of
residence, ethnicity) of the study populations [11]. These
are important factors to consider for health equity and the
lack of reporting of these elements demonstrates the need
to improve reporting of equity in systematic reviews, and
to increase the overall investment in systematic reviews
that can provide a clear emphasis on considerations of
equity. See Box 1 for a description of the terminology
related to disadvantaged populations that is used in this
paper.
Reporting guidelines have been shown to improve
reporting of different study designs [12,13]. The Preferred
Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) is a 27-item checklist to ensure
complete and transparent reporting of the methods used
in systematic reviews [14]. However, the original PRISMA
statement did not include items specific for reporting on
considerations of equity. Equity considerations include
the definition of disadvantaged populations, methods to
include equity considerations in analyses, and applicability
of the evidence to other settings or populations. We devel-
oped an equity extension of the PRISMA statement called
PRISMA-E 2012 to respond to these needs [15]. As of July
8, 2015, the PRISMA-E 2012 reporting guideline has been
viewed almost 16,000 times, downloaded 2,661 times, cited
50 times (Scopus), and shared 109 times using Twitter (99
tweets by 70 users according to Altmetrics). It is also cited
as a reference for the World Health Organization Handbook
on Guideline Development, the Oxford Textbook of Public
Health, the Public Health Agency of Canada guidance, the
Canadian Institutes of Health Research instructions for
applicants, and the Journal of the Society for Social Work
and Research. The Spanish version of PRISMA-E 2012,
published in July 2013, has been downloaded 477 times
as of November 17, 2014 (SciELO) and has received
1,474 visits on the Journal’s Web site [16].
To further facilitate and promote the use of the
guideline of equity issues in systematic review (PRISMA-
E 2012), we developed this explanation and elaborationto describe each of the items and provide examples from
existing reviews to demonstrate good reporting.2. Scope of PRISMA-E 2012
The PRISMA-E 2012 checklist was developed to improve
transparency and completeness of reporting of systematic
reviews of intervention studies with a focus on health equity.
We define systematic reviews of intervention studies with a
major focus on health equity as those designed to
(1) Assess effects of interventions targeted at disadvan-
taged or at-risk populations (e.g., school feeding for
disadvantaged children [17]). These may not include
equity outcomes but by targeting disadvantaged
populations will reduce inequities.
(2) Assess effects of interventions aimed at reducing
social gradients across populations or among
subgroups of the population (e.g., interventions to
reduce the social gradient in smoking, obesity
prevention in children, interventions delivered by
lay health workers [15,18e20]).
In the PRISMA-E 2012 statement, we had a third type of
systematic review focused on health equity, those that are
not aimed at reducing inequities but where it may be impor-
tant to understand the equity effects. For example, we had
previously categorized the review examining lay health
workers in this category. We have now grouped this review
into the second type of review described previously.
In 2010, approximately 20% of systematic reviews in-
dexed in MEDLINE met at least one of the aforementioned
criteria [21,22]. These reviews may not include equity as an
outcome, but may target disadvantaged populations, or
assess differences of the effect of the intervention among
disadvantaged populations.
The PRISMA-E 2012 items are focused on health equity
but may also apply to systematic reviews in nonhealth areas
which address questions about inequity such as education,
transport, justice, or social welfare. Additionally, some
items in the checklist may be relevant to all systematic
reviews but have been included in this extension because
of their specific importance to health equity. These items
are additions or modifications to the existing PRISMA
statement items, to incorporate a focus on equity. For each
item, the original PRISMA item is listed and the PRISMA-
E 2012 extension item is noted in the following.3. Methods PRISMA-E 2012 reporting guideline
To develop the PRISMA-E 2012 reporting guideline, we
followed the series of steps recommended by Moher et al.
(2010), as reported in the previously published article
[23]. The first step was to identify need and review the
literature. We conducted a systematic review and a
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survey whose respondents included systematic review
authors, policy makers, and systematic review funders
[15]. Finally, we held a consensus meeting of international
experts from February 9e10, 2012 at the Rockefeller
Foundation’s Bellagio Conference Center in Bellagio, Italy.
We took detailed minutes at the meeting and used these
minutes to revise the PRISMA-E statement and develop
this explanation and elaboration document. The complete
PRISMA-E 2012 checklist is provided in Table 1.
3.1. How to use this article?
The format of this document is similar to the format
used in other explanation and elaboration documents
[25e29]. We feel this explanation and elaboration article
is an important contribution to the literature because it pro-
vides the detailed rationale, evidence, whenever available,
and an exemplar, for recommending each item as well as
examples of good practice. We recommend authors use this
document in conjunction with the PRISMA-E 2012 state-
ment and with the original PRISMA statement and explana-
tion and elaboration articles. We use the term ‘‘we’’ to refer
to the consensus panel that met to finalize the PRISMA-
Equity 2012 reporting guidelines in February 2012, as well
as those who were unable to attend but contributed to the
final reporting guidelines.
3.1.1. Item 1: title
Standard PRISMA item: Identify the report as a system-
atic review, meta-analysis, or both.
In addition, for equity-focused systematic reviews: Iden-
tify equity as a focus of the review, if relevant, using the
term equity.
3.1.1.1. Examples
B ‘‘Inequity in childhood immunization in India: a sys-
tematic review’’ [30].
B ‘‘Can cost-effectiveness analysis integrate concerns
for equity? Systematic review’’ [31].3.1.1.2. Explanation. Equity-focused systematic reviews
need a concise title that includes the term ‘‘equity’’ or
‘‘inequity.’’ At the consensus meeting, the panel felt
strongly that a consistent term was needed in the title to
help identify equity-focused reviews, and we chose the
term ‘‘equity’’ because of our focus on unfair inequalities
in health. Indexing of electronic databases is poor for terms
relating to health equity or disadvantaged or vulnerable
populations; therefore, we suggest including ‘‘equity’’ in
the title will facilitate searching for equity-focused reviews.
Not all systematic reviews will include equity in the title so
to improve searchability, ‘‘equity’’ should be included in
the abstract and/or keywords. This will also help policy
makers find equity-focused systematic reviews. In a searchof systematic reviews published in the last year in MED-
LINE, we only found 11 with ‘‘equity’’ in the title and
73 with equity in the title and/or abstract (See Web
Table 1 at www.jclinepi.com).3.1.2. Item 2: abstract
Standard PRISMA item: Provide a structured summary
including, as applicable: background; objectives; data
sources; study eligibility criteria, participants, and interven-
tions; study appraisal and synthesis methods; results; limi-
tations; conclusions and implications of key findings;
systematic review registration number.
In addition, for equity-focused systematic reviews: State
research question(s) related to health equity.
3.1.2.1. Example
B ‘‘We aimed to systematically assess current evidence
for the association between socioeconomic position
(SEP) and caries. We included studies investigating
the association between social position (determined
by own or parental educational or occupational back-
ground, or income) and caries prevalence, experience,
or incidence’’ [32].
‘‘Our primary outcome is the utilization of postnatal care
(PNC) services, and determinants of concern are as fol-
lows: (1) socioeconomic status (SES) (e.g., income, educa-
tion); (2) geographic determinants (e.g., distance to a health
center, rural vs. urban residence); and (3) demographic
determinants (e.g., ethnicity, immigration status)’’ [33].3.1.2.2. Explanation. The abstract of the review needs to
indicate whether the research questions and objectives are
of relevance to equity or specific populations because some
readers, including those making decisions about health pro-
grams and policies, may only have access to the abstract (or
only read the abstract). Thus, we recommend research
questions related to health equity should be reported in
the abstract to facilitate their retrieval for decision making.
We also recommend describing the type of inequities ad-
dressed by the review (e.g., health outcomes, health service
coverage or access, financial risk).
Item 2A: in addition, for equity-focused systematic re-
views: Present results of health equity analyses (e.g., sub-
group analyses or meta-regression).
3.1.2.3. Example
B ‘‘No strong evidence of differential effects was found
for smoking restrictions in workplaces and public pla-
ces, although those in higher occupational groups
may be more likely to change their attitudes or
behavior. Smoking restrictions in schools may be
more effective in girls. Restrictions on sales to minors
may be more effective in girls and younger children.
Increasing the price of tobacco products may be more
Table 1. Checklist of items for reporting equity-focused systematic reviews
Section Item Standard PRISMA item Extension for equity-focused reviews
Title
Title 1 Identify the report as a systematic review, meta-
analysis, or both.
Identify equity as a focus of the review, if relevant,
using the term equity.
Abstract
Structured
summary
2 Provide a structured summary including, as
applicable: background; objectives; data sources;
study eligibility criteria, participants, and
interventions; study appraisal and synthesis
methods; results; limitations; conclusions and
implications of key findings; systematic review
registration number.
State research question(s) related to health equity.
2A Present results of health equity analyses (e.g.,
subgroup analyses or meta-regression).
2B Describe extent and limits of applicability to
disadvantaged populations of interest.
Introduction
Rationale 3 Describe the rationale for the review in the context of
what is already known.
Describe assumptions about mechanism(s) by which
the intervention is assumed to have an impact on
health equity.
3A Provide the logic model/analytical framework, if done,
to show the pathways through which the
intervention is assumed to affect health equity and
how it was developed.
Objectives 4 Provide an explicit statement of questions being
addressed with reference to PICOS.
Describe how disadvantage was defined if used as
criterion in the review (e.g., for selecting studies,
conducting analyses, or judging applicability).
4A State the research questions being addressed with
reference to health equity.
Methods
Protocol and
registration
5 Indicate if a review protocol exists, if and where it can
be accessed (e.g., Web address), and, if available,
provide registration information including
registration number.
Eligibility
criteria
6 Specify study characteristics (e.g., PICOS, length of
follow-up) and report characteristics (e.g., years
considered, language, publication status) used as
criteria for eligibility, giving rationale.
Describe the rationale for including particular study
designs related to equity research questions.
6A Describe the rationale for including the outcomes
(e.g., how these are relevant to reducing inequity).
Information
sources
7 Describe all information sources (e.g., databases with
dates of coverage, contact with study authors to
identify additional studies) in the search and date
last searched.
Describe information sources (e.g., health, nonhealth,
and gray literature sources) that were searched that
are of specific relevance to address the equity
questions of the review.
Search 8 Present full electronic search strategy for at least one
database, including any limits used, such that it
could be repeated.
Describe the broad search strategy and terms used to
address equity questions of the review.
Study selection 9 State the process for selecting studies (i.e.,
screening, eligibility, included in systematic
review, and, if applicable, included in the meta-
analysis).
Data collection
process
10 Describe method of data extraction from reports (e.g.,
piloted forms, independently, in duplicate) and any
processes for obtaining and confirming data from
investigators.
Data items 11 List and define all variables for which data were
sought (e.g., PICOS, funding sources) and any
assumptions and simplifications made.
List and define data items related to equity, where
such data were sought (e.g., using PROGRESS-Plus
or other criteria, context).
Risk of bias in
individual studies
12 Describe methods used for assessing risk of bias of
individual studies (including specification of
whether this was done at the study or outcome
level), and how this information is to be used in any
data synthesis.
(Continued )
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Table 1. Continued
Section Item Standard PRISMA item Extension for equity-focused reviews
Summary measures 13 State the principal summary measures (e.g., risk
ratio, difference in means).
Synthesis of results 14 Describe the methods of handling data and
combining results of studies, if done, including
measures of consistency (e.g., I2) for each meta-
analysis.
Describe methods of synthesizing findings on health
inequities (e.g., presenting both relative and
absolute differences between groups).
Risk of bias across
studies
15 Specify any assessment of risk of bias that may affect
the cumulative evidence (e.g., publication bias,
selective reporting within studies).
Additional analyses 16 Describe methods of additional analyses (e.g.,
sensitivity or subgroup analyses, meta-regression),
if done, indicating which were prespecified.
Describe methods of additional synthesis approaches
related to equity questions, if done, indicating
which were prespecified.
Results
Study selection 17 Give numbers of studies screened, assessed for
eligibility, and included in the review, with reasons
for exclusions at each stage, ideally with a flow
diagram.
Study characteristics 18 For each study, present characteristics for which data
were extracted (e.g., study size, PICOS, follow-up
period) and provide the citations.
Present the population characteristics that relate to
the equity questions across the relevant
PROGRESS-Plus or other factors of interest.
Risk of bias within
studies
19 Present data on risk of bias of each study and, if
available, any outcome level assessment (see item
12).
Results of individual
studies
20 For all outcomes considered (benefits or harms),
present, for each study: (1) simple summary data
for each intervention group; (2) effect estimates
and confidence intervals, ideally with a forest plot.
Synthesis of results 21 Present results of each meta-analysis done, including
confidence intervals and measures of consistency.
Present the results of synthesizing findings on
inequities (see item 14).
Risk of bias across
studies
22 Present results of any assessment of risk of bias
across studies (see item 15).
Additional analysis 23 Give results of additional analyses, if done (e.g.,
sensitivity or subgroup analyses, meta-regression
[see item 16]).
Give the results of additional synthesis approaches
related to equity objectives, if done (see item 16).
Discussion
Summary of evidence 24 Summarize the main findings including the strength
of evidence for each main outcome; consider their
relevance to key groups (e.g., health care providers,
users, and policy makers).
Limitations 25 Discuss limitations at study and outcome level (e.g.,
risk of bias), and at review level (e.g., incomplete
retrieval of identified research, reporting bias).
Conclusions 26 Provide a general interpretation of the results in the
context of other evidence, and implications for
future research.
Present extent and limits of applicability to
disadvantaged populations of interest and describe
the evidence and logic underlying those judgments.
26A Provide implications for research, practice, or policy
related to equity where relevant (e.g., types of
research needed to address unanswered questions).
Funding
Funding 27 Describe sources of funding for the systematic review
and other support (e.g., supply of data); role of
funders for the systematic review.
Abbreviations: PICOS, participants, interventions, comparisons, outcomes, and study design; PRISMA, Preferred Reporting Items for System-
atic Reviews and Meta-Analysis.
This checklist should be read in conjunction with the statement and explanation and elaboration document.
72 V. Welch et al. / Journal of Clinical Epidemiology 70 (2016) 68e89effective in reducing smoking among lower income
adults and those in manual occupations, although
there was also some evidence to suggest that adults
with higher levels of education may be more price
sensitive. Young people aged less than 25 years are
also affected by price increases, with some evidencethat boys and nonwhite young people may be more
sensitive to price’’ [18].
3.1.2.4. Explanation. Findings related to equity questions
should be presented in the abstract along with the main
results. In addition, the abstract needs to differentiate
73V. Welch et al. / Journal of Clinical Epidemiology 70 (2016) 68e89between the main analyses and other analyses as well as
any null findings. Of 182 abstracts, 42% do not describe
the direction of the main effect in words, and 25% do
not provide numerical results [34]. For equity-focused re-
views, we have found that equity findings (e.g., subgroup
analyses by SES or other indicators) are not well reported
in the abstract. Including the equity findings in the
abstract may facilitate finding equity-focused reviews.
As mentioned previously, some readers only read or have
access to the abstract. We felt that including equity-
findings in the abstract will be helpful for users to
determine whether the review is of interest. Therefore,
the abstract should describe all relevant effects on health
equity, both beneficial and harmful, as well as the
methods used to assess health equity [35].
As recommended by PRISMA for abstracts [36], authors
should report the main results in both numbers and words to
meet the needs of different users.
Item 2B: in addition, for equity-focused systematic re-
views: Describe extent and limits of applicability to disad-
vantaged populations of interest.
3.1.2.5. Example
B ‘‘Conditional cash transfer programs have been the
subject of some well-designed evaluations, which
strongly suggest that they could be an effective
approach to improving access to preventive services.
Their replicability under different conditionsd
particularly in more deprived settingsdis still unclear
because they depend on effective primary health care,
and mechanisms to disburse payments. Further
rigorous evaluative research is needed, particularly
where conditional cash transfers (CCTs) are being
introduced in low-income countries, for example, in
Sub-Saharan Africa or South Asia’’ [37].
3.1.2.6. Explanation. Because the abstract may be all that a
reader accesses, it is important that the abstract reports the
extent and limits of applicability of the findings of the review
in relation to equity concepts. We felt this information is
important to all consumers and users of the review, including
patients, practitioners, policy makers, press, and the public.
The reporting of applicability is not intended to be a
recommendation for practice or policy. It is instead in-
tended to provide the reader with information regarding
the primary studies and the results of the review and how
the results of equity considerations apply. Although there
is insufficient space to report applicability considerations
for all populations, we felt that applicability to the target
population of the review should be reported.3.2. Introduction section
3.2.1. Item 3: rationale
Standard PRISMA item: Describe the rationale for the
review in the context of what is already known.In addition, for equity-focused systematic reviews:
Describe assumptions about mechanism(s) by which the
intervention is assumed to have an impact on health equity.
3.2.1.1. Examples
B ‘‘CCT programs are justified on the grounds that
demand-side subsidies are needed to address con-
straints and bottlenecks of service delivery. CCT pro-
grams usually aim to increase demand for preventive
health services and education because these services
have positive spillover effects that justify the expense.
CCTs help overcome barriers to access of services.
These programs address social equity concerns
because CCT can help to ‘‘level the playing field’’
thus creating equal opportunities’’ [37].
B ‘‘Many lay health worker programs aim to address
inequity by providing services to underserved com-
munities’’ [38].
3.2.1.2. Explanation. If available, systematic reviews with
a focus on health equity should explicitly describe the as-
sumptions about the effects of the intervention on health
equity, or drivers of health inequity. Assumptions about
outcomes along the causal chain and these hypotheses
about health equity may be articulated using different
methods such as a program theory and can then be tested
empirically with preplanned analyses in the review
[39,40]. The review should describe a priori how and
why interventions are expected to work and the influence
of factors such as setting and participant and program char-
acteristics. This explicit reporting of assumptions and un-
derlying hypotheses will help the reader understand the
choice of methods to assess effects on health equity and
the interpretation of results within the framework of these
hypotheses.
Item 3A: in addition, for equity-focused systematic re-
views: Provide the logic model/analytical framework, if
done, to show the pathways through which the interven-
tion is assumed to affect health equity and how it was
developed.3.2.1.3. Examples. Fig. 1; [41,42].
Fig. 2; [43].
3.2.1.4. Explanation. Health equity is influenced by multi-
ple interacting factors such as context, setting, population
characteristics, environment, public policy setting, health
facility factors, health provider factors [4,44,45]. A visual
framework, or logic model, can show the links between these
factors, the program or intervention of interest, and the
hypothesized effects on health equity. It can be used to show
hypothesized pathways of influence on health equity, to focus
the review, define the inclusion criteria, identify intermediate
outcomes and harms, define the search strategy, and plan
subgroup and effect modifier analyses [46]. For example,
Fig. 1. Item 3A, Example 1danalytic framework. This is an example of a ‘‘funnel of attrition’’ [41,42].
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shows that low SES and household size may increase the risk
of substitution (less food at home), thus decreasing the
observed effects of preschool feeding [47]. A visual
framework can be useful for policy makers and decision
makers who seek to answer questions about the effects of
both targeted and universal interventions and how these
programs will work in their policy/decision-making settings
and system. For complex interventions, a visual framework
can help the reader unpack the ‘‘black box,’’ thus showing
how the intervention might affect different subgroups of
the population and can be used as a tool for articulating
subgroup analyses a priori.
Many different methods exist for developing a logic
model, and different logic models have been developed
for the same question. Guidance for how to construct a
logic model is available from the Cochrane Public Health
Group and the Kellogg Foundation [48e51].Fig. 2. Item 3A, Example 2danalytic framework3.2.2. Item 4: objectives
Standard PRISMA item: Provide an explicit statement of
questions being addressed with reference to participants, in-
terventions, comparisons, outcomes, and study design
(PICOS).
In addition, for equity-focused systematic reviews:
Describe how disadvantage was defined if used as criterion
in the review (e.g., for selecting studies, conducting ana-
lyses, or judging applicability).
3.2.2.1. Example
B ‘‘For the purposes of this review, the term ‘‘disadvan-
taged’’ is taken to denote women whom the primary
investigators considered to be of low SES or educa-
tionally disadvantaged, or who are less than the age
of 20 years (children born to teenage mothers in the
UK have been estimated to have a 63% increased. This is an example of a logic model [43].
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ing for children in single-parent households’’ [55].
B ‘‘Parents with children up to the age of school entry
and who were socially disadvantaged in respect of
poverty, lone parenthood, or ethnic minority status’’
[17].
B ‘‘We will retrieve studies implemented in low- and
middle-income countries (LMICs), as defined by The
World Bank Group’s classification. which study
access to or utilization of PNC services by birthing
women living in resource strained settings’’ [33].3.2.2.2. Explanation. Description of the specific popula-
tion in the PICOS framework does not encompass explicit
definition of how disadvantage or risk of inequity will be
assessed, for example, in reference to which group, disad-
vantaged by what mechanisms, and for which outcomes.
Populations are at risk of health disadvantage for many
different reasons which may interact with each other. There
are many examples of factors that may contribute to disad-
vantage, and these may interact with each other, such as
geographical isolation, lack of access to health facilities,
biologic vulnerability, historical oppression, social exclu-
sion, health or language literacy, low resource settings,
inadequate health systems, inadequate health insurance,
health provider attitudes, stigmatization, and discrimination
[6]. Systematic review authors can group such factors using
the PROGRESS-Plus acronym; place of residence, race/
ethnicity/culture/religion, occupation, gender/sex, religion,
social capital, SES [6,52]. However, grouping populations
that share one characteristic across PROGRESS-Plus may
lead to overgeneralization because people within one
category are heterogeneous (e.g., women range from poor
to wealthy, with very different personal histories and
exposures to health risks).
An explicit definition of how disadvantage will be
assessed in the systematic review, either for targeted inter-
ventions or for subgroup analyses of universal interventions,
is necessary to increase the likelihood that similar groups of
people are compared, to make explicit the proposed reasons
those people are considered disadvantaged, to explain why
and how the program is expected to work for people at
different risk of health disadvantage, and to facilitate judg-
ments about applicability in different settings and popula-
tions. If disadvantage is used as a criterion, it needs to be
defined, as well as the proposed reasons for disadvantage
(e.g., biologic, societal), and the comparator or reference
group against which disadvantage is assessed. Disadvantage
and vulnerability may be poorly reported in primary studies.
However, systematic review authors should describe how
they have operationalized their definition of disadvantage
or inequity in their inclusion criteria, analyses, and
judgments of applicability. For example, if economically
disadvantaged populations are the focus of the review, then
a description of this population should be provided.Item 4A: in addition, for equity-focused systematic
reviews: State the research questions being addressed with
reference to health equity.
3.2.2.3. Examples. Two objectives are as follows:
B ‘‘To determine the effectiveness of school feeding
programs in improving physical and psychosocial
health outcomes for low-income school children.’’
‘‘To compare the effectiveness of school feeding pro-
grams for socioeconomically disadvantaged children
and advantaged children’’ [53].
B ‘‘To assess the impact on maternal and infant health
and on infant development of programs offering home
support in addition to the standard service for teenaged
mothers (aged less than 20 years) who had recently
given birth and who were socially or economically
disadvantaged, for example, because they were poor,
lived inner city, or were single parents’’ [54].
3.2.2.4. Explanation. If assessing the impact on inequities
is an objective of the review, the research questions related
to this objective should be stated. Potentially important sub-
group effects are differences in the relative effect that are
large enough that users might make different decisions
based on the subgroup effect than they would be based
on the overall effect. Review authors should give consider-
ation to all potentially disadvantaged groups for which the
intervention might have a different effect based on the
intervention’s mechanism of action; including economic
status, employment or occupation, education, place of resi-
dence, gender, and ethnicity.
Consideration of differences in relative effects for disad-
vantaged populations should be addressed similarly to any
other subgroup analysis. As such, authors should distin-
guish between protocol and review items. The protocol
should indicate plans for any subgroup analyses, including
specifying which subgroups will be investigated, the pre-
dicted direction of the subgroup effect, and the indirect
evidence supporting the prediction (e.g., biological or so-
ciological rationale; studies of other relevant populations,
interventions, or outcomes) [55,56]. Only a small number
of subgroups (i.e., only those for which there is a plausible
reason such as indirect evidence for anticipating a subgroup
effect) should be investigated.3.3. Methods section
3.3.1. Item 6: eligibility criteria
Standard PRISMA item: Specify study characteristics
(e.g., PICOS, length of follow-up) and report characteristics
(e.g., years considered, language, publication, status) used
as criteria for eligibility, giving rationale.
In addition, for equity-focused systematic reviews:
Describe the rationale for including particular study designs
related to equity research questions.
76 V. Welch et al. / Journal of Clinical Epidemiology 70 (2016) 68e893.3.1.1. Examples
B ‘‘Cross-sectional quantitative study designs, qualita-
tive study designs, or a combination of the two
(mixed-methods studies). Specifically, we included,
first, any type of cross-sectional study design report-
ing quantitative data. Second, qualitatively based
studies had to have used either individual interviews
or focus group interviews to collect data about female
genital mutilation/cutting (FGM/C) and used qualita-
tive data analysis methods, such as thematic analysis,
to be eligible for inclusion. Third, mixed-methods
studies that incorporated both quantitative and quali-
tative components where the research design matched
the nominated study designs were included. Both the
quantitative and the qualitative components of the
study were subjected to the same inclusion criteria
as the mono-methods studies, and the study was only
included when the inclusion criteria were met’’ [57].
B ‘‘We included qualitative studies and studies using
descriptive statistics which met the following criteria:
1. reported on interventions as identified as ‘‘farmer
field schools,’’ although not necessarily the same
interventions as those included in the review of ef-
fects (review question 1);
2. assessed determinants of service delivery quality,
knowledge acquisition, adoption of technological
improvements, diffusion, or sustainability (either
directly or indirectlydfor example, studies that
were relevant to addressing barriers to and enablers
of farmer field schools [FFSs] effectiveness).’’
[58].
3.3.1.2. Explanation. Evidence on equity impacts may
come from a range of study designs, depending on the ques-
tion, and the study designs included in a systematic review
should be chosen on the basis of the question according to
their ‘‘fitness for purpose’’ [59]. The evidence of effects
may have been assessed using randomized controlled trials
(RCTs) or other intervention study designs such as interrup-
ted time series or controlled beforeeafter study. However,
for many equity-focused reviews examining social or public
health interventions, the context in which the intervention
operates is important and may be reported in qualitative
studies [59]. Evaluations of policy-level and other interven-
tions that have implications for reducing inequity and may
provide important insight into the effects on equity may have
been evaluated using nonrandomized designs (e.g., natural
experiments).
Authors should be able to capture different types of ev-
idence through the inclusion of different study designs but
should justify inclusion of these designs and provide the
rationale. For example, barrier and facilitator data collec-
tion and analysis often requires quantitative and qualitative
data. New authors may not be aware of the rationale for
preferred study designs. Although most systematic reviewsjust list study design without rationale, the need to explain
the rationale is not just an issue for equity, and it should al-
ways be reported.
Item 6A: in addition, for equity-focused systematic
reviews: Describe the rationale for including the outcomes
(e.g., how these are relevant to reducing inequity).3.3.1.3. Examples
B ‘‘Other smoking-related outcomes included compli-
ance with age-of-sale legislation, density of adver-
tising and vending machines, brand appeal, and
awareness and receptivity to antismoking campaigns.
This broad range of smoking-related outcomes was
included to encompass the diverse ways in which
tobacco control policies can influence youth
smoking-related outcomes’’ [60].
B ‘‘Changes in equity of accessdincreased access for
disadvantaged groups or a reduction in gaps in
coveragedcould also be an important outcome mea-
sure. This required a preliminary analysis and catego-
rization of the population of interest along a
socioeconomic scale. We accepted any relevant meth-
odology (e.g., wealth/asset index) provided it was
rigorous and described in detail’’ [37].3.3.1.4. Explanation. As with all systematic reviews, out-
comes need to be selected based on their relevance to the
relevant stakeholder and/or user group (e.g., subjects/pa-
tients, practitioner [and the patient-practitioner dyad], the
public, policy makers, and politicians). Equity-focused
systematic reviews must, in addition, consider the relevance
and importance of outcomes across categories of disadvan-
tage that are deemed relevant for the review, including both
health and nonhealth outcomes. Nonehealth-related
outcomes can have direct impacts on health and equity.
For example, the Whitehall study found that employment
grade levels are related to health differences in which peo-
ple with lower grade jobs have higher rates of mortality and
diseases, such as ischemic heart disease, and lower self-
perceived health status [61].
In addition, measures may need to be developed and/or
adapted to ensure that the methodology does not disadvan-
tage participation of bias results across populations. Other
situations are often found when a measure may be used
across a population, and where the intervention effective-
ness is analyzed according to cultural diversity within the
population. For example, a systematic review of culturally
appropriate health education assessed the influence of
culturally adapted measurement tools on knowledge out-
comes using sensitivity analysis [62]. The importance of
outcomes for different settings and populations needs to
be rated when selecting major outcomes, for example, in
Summary of Findings (SOFs) tables for Cochrane reviews.
An SOF table presents the main findings of the review for
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ity of the evidence [63]. SOFs are intended for those using
the review, such as decision makers [64].
Context, inconvenience, and burden (e.g., financial
burden) for populations need to be considered as potentially
important outcomes in equity-focused reviews even if they
are not commonly reported in primary studies. Financial
burden may be relatively greater for those who are poor
and other burdens, such as stigma or travel time, may be
different for different populations.
Equity of access to care and coverage of health services
are important outcomes for some interventions which seek
to improve access. Horizontal equity implies equal health
care for equal need, whereas vertical equity implies greater
health care for greater need. Authors should take a prag-
matic approach to assessing equity of access.
3.3.2. Item 7: information sources
Standard PRISMA item: Describe all information sour-
ces (e.g., databases with dates of coverage, contact with
study authors to identify additional studies) in the search
and date last searched.
In addition, for equity-focused systematic reviews:
Describe information sources (e.g., health, nonhealth, and
gray literature sources) that were searched that are of spe-
cific relevance to address the equity questions of the review.
3.3.2.1. Examples
B ‘‘We chose to restrict our search of electronic data-
bases to the 20 databases that had produced the high-
est yield in the search for a previous systematic
review on a related topic, the health effects of new
roads.
We developed our search syntax iteratively. We first con-
ducted a scoping search with a provisional set of terms,
retrieved the 100 most relevant abstracts, and then added
additional indexing or text word terms used in those ref-
erences to our search strategy. We then adapted the
search syntax for each database or interface used. We
did not limit the search using terms for study design.
We decided not to attempt a ‘‘systematic’’ internet
search. Instead, we used three quality assured gateway
sites (http://www.omni.ac.uk, http://www.sosig.ac.uk,
and http://www.eevl.ac.uk) and our own knowledge to
generate lists of potentially relevant Web sites, from
which we selected a purposive sample of 16 sites that
contained bibliographies or searchable databases of doc-
uments. These represented a range of types of organiza-
tion (academic, government, and voluntary), countries of
origin (Canada, all the countries of the European Union,
Norway, and the United States of America), and lan-
guage of publication (Danish, English, French, Norwe-
gian, and Swedish)’’ [65].
B ‘‘We searched the following electronic databases for
primary studies:The Cochrane Central Register of Controlled
Trials (CENTRAL), 2009, Issue 1, part of The
Cochrane Library (www.thecochranelibrary.com)
including the Cochrane Effective Practice and
Organization of Care (EPOC) Group Specialized
Register (searched March 3, 2009)
MEDLINE, Ovid In-Process & Other Non-
Indexed Citations and MEDLINE, Ovid (1948
to present) (searched June 24, 2011)
EMBASE, Ovid (1980 to 2009 Week 09)
(searched March 2, 2009)
PsycINFO, Ovid (1806 to February Week 4 2009)
(searched March 4, 2009)
EconLit, Ovid (1969 to February 2009) (searched
March 5, 2009)
Sociological Abstracts, CSA (1952 to present)
(searched March 8, 2009)
Social Services Abstracts, CSA (1979 to present)
(searched March 8, 2009)
LILACS (searched May 6, 2009)
WHOLIS (searched May 7, 2009)
World Bank
Science Citation Index Expanded (SCI-
EXPANDED) (1975 to present) (searched
September 8, 2010)
Social Sciences Citation Index (SSCI) (1975 to
present) (searched September 8, 2010). In addition,
we selected relevant databases from the LMIC
database list at http://epocoslo.cochrane.org. We
did not search CINAHL or International Pharma-
ceutical Abstracts, so it is possible that studies
relating to nursing or pharmaceuticals were
missed. However, the general searches, including
in Web sites focused on this topic, did not suggest
that we had missed any relevant studies. We will
add these databases when the review is updated’’
[66].3.3.2.2. Explanation. Equity-focused reviews often go
beyond issues of health and bridge other disciplines and
thus information sources. For equity-focused systematic re-
views, sources of information beyond the well-known
health databases may be required. The search strategy
may require inclusion of sources of information from
different disciplines and different databases (e.g., sociolog-
ical abstracts, IDEAhealth, nonhealth transportation or
environmental content databases, and discipline-specific
gray literature). Authors should describe all sources of in-
formation used for the search and provide a brief descrip-
tion of each and justify why these information sources
were considered necessary and appropriate.
Some relevant information may be available only to
members of a certain association or working group. It
would therefore be helpful for authors to report the acces-
sibility of the sources of information in addition to Web site
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where the information has originated.
3.3.3. Item 8: search
Standard PRISMA item: Present full electronic search
strategy for at least one database, including any limits used,
such that it could be repeated.
In addition, for equity-focused systematic reviews:
Describe the broad search strategy and terms used to
address equity questions of the review.
3.3.3.1. Example
B See Web Table 2 at www.jclinepi.com.3.3.3.2. Explanation. Authors of equity-focused system-
atic reviews should report the search strategy and search
terms used to identify sources relevant to the equity
questions. Equity questions may require comprehensive
text-word searches to identify specific populations, multi-
component interventions, or settings of interest which
may require combinations of text words. Additionally, eq-
uity relevant reviews may relate to stigmatized populations,
where language has evolved to identify the communities in
a nonstigmatized way. Any search terms used should be
clearly reported to ensure that the reader can duplicate
the search. We do not suggest limiting the search to
equity-relevant terms unless these equity search strategies
have been validated. For example, the Cochrane ChildBox 1 Terminology related to disadvantaged
populations
To describe the populations who are experiencing
inequitable differences, we use the term ‘‘disadvan-
taged’’ although we recognize that this term may
not be acceptable to all. In a methodology review
of equity assessment, disadvantage was defined in
terms of the avoidability or preventability of health
inequalities (12 of 34 studies) [11] by focusing on
populations that have experienced health inequities
(e.g., Aboriginal populations).
We have chosen to use the term ‘‘disadvantaged’’
for PRISMA-E 2012 because we felt that despite its
limitations (e.g., that it may be considered a conde-
scending or paternalistic term), the term ‘‘disadvan-
taged’’ more clearly defines a population that is
experiencing or has experienced health inequities.
Whereas vulnerability encompasses a combination
of risk, exposure, and resilience that do not always
lead to health inequities, and other terms such as
‘‘marginalized’’ are too narrowly focused and do
not encompass the breadth of settings, contexts, and
health inequities of interest.Health filter has been validated [67]. Other validated search
filters are collected in a repository by the InterTASC Infor-
mation Specialists’ Sub-Group Search Filter Resource.
There is also ongoing work to validate a filter for identi-
fying sex-specific analyses [68]. See Box 2 for more infor-
mation on searching.
3.3.4. Item 11: data items
Standard PRISMA item: List and define all variables for
which data were sought (e.g., PICOS, funding sources) and
any assumptions and simplifications made.
In addition, for equity-focused systematic reviews: List
and define data items related to equity, where such data
were sought (e.g., using PROGRESS-Plus or other criteria,
context).
3.3.4.1. Example
B ‘‘.extracted data on study design, description of the
intervention (including process), details on partici-
pants (including age, sex, number in each group),
length of intervention, definition of poor/low income,
other sociodemographic variables, including place of
residence, race/ethnicity, age, and nutritional status,
critical appraisal (see the following), physical, cogni-
tive, and behavioral outcomes. We had planned to
extract data on cost-effectiveness, but found none.
Where possible, we recorded effects by SEP’’ [53].3.3.4.2. Explanation. It is important for equity-focused
systematic reviews to report all items for which data were
sought even if the information was not available from the
primary studies. Authors should explain the reasons for
seeking data on these characteristics. If possible, authors
should consider making their data extraction forms avail-
able online (See Web-only Appendices at www.jclinepi.
com) or by request so that others may use or amend the
forms in their own reviews.
Other data items that relate to the context of the popula-
tion or intervention should also be reported as well as any
interactions between context and PROGRESS-Plus factors.
Each characteristic requires careful consideration regardingBox 2 A note about searching
Caution should be used when developing the
search strategy. Limiting the search using equity-
related search terms is not recommended as many
studies are not indexed using equity-related terms
and potentially relevant studies could be missed.
For equity-focused reviews, the search strategy may
need to be broadened to reduce the risk of missing
potentially included studies. Review authors should
plan more time for screening.
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with other contextual elements and how they influence
health inequities. For example, there is no agreed system
for classifying race, ethnicity, and culture, particularly
across different countries [6].
PROGRESS-Plus is one acronym that can be used to
describe disadvantage [6,52,69]. However, other frame-
works for describing disadvantage and inequity exist and
may also be used to capture equity-relevant data items.
We support PROGRESS-Plus because it is easy to
remember and is inclusive of all factors that may indicate
disadvantage. About 68% of systematic reviews describe
the included population using one or more of the
PROGRESS-Plus criteria, and 13% assess the effects of in-
terventions disaggregated across one or more of these char-
acteristics [24].
3.3.5. Item 14: synthesis of results
Standard PRISMA item: Describe the methods of
handling data and combining results of studies, if done,
including measures of consistency (e.g., I2) for each
meta-analysis.
In addition, for equity-focused systematic reviews:
Describe methods of synthesizing findings on health ineq-
uities (e.g., presenting both relative and absolute differ-
ences between groups).
3.3.5.1. Example
B ’’ Studies demonstrating an overall effect on anthro-
pometric outcomes were initially categorized accord-
ing to whether they were effective or not effective
among lower SEP groups. Within these categories,
we then analyzed studies to identify common charac-
teristics between interventions, including the degree
to which they addressed structural barriers to behav-
ioral change; as noted earlier, particular structural
barriers may be more or less prevalent among
different SEP groups in a population’’ [70].3.3.5.2. Explanation. There is a need for clear and explicit
reporting of choices regarding analyses about health ineq-
uity and their rationale a priori. This includes reporting
what will be compared and how these comparisons will
be made. There are over 20 different approaches available
to measure health inequalities between two groups (e.g.,
rate ratio, rate difference, low-to-high ratio), or between
more than two groups (e.g., slope index of inequality, con-
centration index, index of dissimilarity) [71]. Despite
vigorous debate about the attributes, measurement proper-
ties and implications of different measures and choice such
as the referent group, there is no single accepted measure of
health inequalities, and all are subject to limitations [72].
Furthermore, the selection of how to measure health in-
equalities may bias the interpretation of results [71]. For
example, the interpretation of any measure of changes inhealth inequalities over time depends on whether the
outcome is an adverse effect or beneficial outcome, and
on the baseline prevalence [73]. Authors should report the
methods used to synthesize findings to ensure sufficient in-
formation Fig. 3 [18].
Measures of health inequalities may be useful as an
input for population or economic models for projecting
population impact on health inequalities. Considerations
for choosing a measure of health inequalities are as follows:
(1) interpretability; (2) ease of calculation; and (3) informa-
tion available from primary studies. Although there is no
agreement on the best approach, selection of measures of
health inequalities needs to consider the advantages, data
requirements, and limitations of these approaches. The
choice of reference point (comparator), method of assessing
differences (relative or absolute), measurement of differ-
ences, or end of study outcomes affects the difference
observed between two or more groups [74]. Some measures
(e.g., Gini, concentration index) may be less well under-
stood by the users.
The measurement of health inequity depends on charac-
teristics of the outcome measure and choices about compar-
isons, such as, whether the outcome is desirable or
undesirable, baseline prevalence, and absolute or relative
differences [74,75]. This was demonstrated with
a beforeeafter study of a coronary artery bypass graft
(CABG) report card program that compared the rates of
CABG surgery between white, black, and Hispanic pa-
tients. The relative difference decreased between white
and black patients for receipt of a CABG, but the absolute
difference increased therefore increasing the disparities be-
tween ethnicities [75,76].
The absolute effect provides the difference in effective-
ness between, whereas the relative effect describes the dif-
ference in effectiveness relative to a reference group, such
as the whole population [77]. Absolute differences can
describe the proportion of the disadvantaged population
affected, or not affected, by the intervention because
disadvantaged populations may have worse health status
and higher risk of adverse outcomes [75]. Another example
(Fig. 2) demonstrates that although the rate of stomach
cancer mortality for men and women declined between the
years 1930 and 2000, the absolute difference between these
rates decreased over that last 50 years while the relative
difference has increased steadily [78]. This demonstrates
that although mortality rates have declined in both groups,
the ratio of male-to-female stomach cancer mortality has
increased (more men than women are dying from stomach
cancer). It would be misleading to present one of these
indicators without the others; therefore, we suggest that
systematic review authors present the absolute and relative
differences.
If the aim of the intervention being studied in the sys-
tematic review is to reduce inequities, authors should report
how they plan to measure the effect on health inequities. If
the review will compare effects in two groups, how will the
Fig. 3. Harvest plot. The ‘‘harvest plot’’ synthesizes anddisplays the evidence to support possible social gradients in the effects of the intervention [18].
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systematic review level? Fig. 4 [78].
3.3.6. Item 16: additional analyses
Standard PRISMA item: Describe methods of additional
analyses (e.g., sensitivity or subgroup analyses, meta-
regression), if done, indicating which were prespecified.
In addition, for equity-focused systematic reviews:
Describe methods of additional synthesis approaches
related to equity questions, if done, indicating which were
prespecified.
3.3.6.1. Examples
B ‘‘Effect modifiers, such as high/low energy, compli-
ance, substitution, and duration of the interventionwere
examined. In addition, study quality was considered
because studies of lower quality often show higher
effect sizes than those of higher quality. For example,
biased outcome assessment is possible if the outcome
assessors are not blinded to study group. This review
tabulated the effects for each study by sorting them
according to these effect modifiers (type of study,
blinding vs. unclear blinding, date of study, and high
vs. low energy) (Kristjansson et al. 2007). The effect
of school feeding on learning outcomes may also be
affected by contextual factors as teacher absenteeism
and availability of learning materials, both of whichmay be worse in more disadvantaged communities’’
[53].
B ‘‘This study examined the influence of program
implementation, program activities, program environ-
ment, and individual characteristics on welfare-to-
work programs. The authors also considered the
unemployment rate for each to determine whether
the programs were affected by the availability of jobs
in the area in which the program was implemented’’
[79].3.3.6.2. Explanation. Understanding how to reduce health
inequities may require additional quantitative or qualitative
analyses, such as causal pathway analyses or process eval-
uations and a greater use of subgroup analyses to explore
the differential effects of public health or population-level
interventions. Implementation of an intervention and its
effectiveness may depend on participant characteristics
such as age, education, gender, social status, context
including the presence of complementary services, setting
characteristics, and intervention characteristics (e.g., fidel-
ity of intervention, delivery). Differences in participant
characteristics, context and intervention design, or delivery
may limit the ability to conduct a meta-analysis. These
characteristics of interventions, setting, and participants
may not be well reported in primary studies or have insuf-
ficient statistical power to find significant effects at the
Fig. 4. Absolute and relative gender disparity in stomach cancer mortality, 1930e2000 [78].
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need to contact the primary study authors for information
regarding subgroup analyses across different characteristics
such as ethnicity and SES. This information may have been
analyzed but not reported in the published articles [82,83].
The move toward open access of trial data may make this
more feasible in the future [84].
Subgroup analyses need to be conducted with caution
and follow guidelines for reducing the likelihood of
false results. Sun et al. [55] have developed criteria for
judging the credibility of subgroup analyses such as
prespecifying the hypothesized direction of effects, using
a test for interaction, and keeping the number of subgroup
analyses few, and justified on the basis of prior empiric
evidence.
Systematic reviews with an equity focus should
document and describe relevant and important characteris-
tics of the participants and settings, as well as implications
for the ability to conduct preplanned analyses.
Numerous additional methods may be used to assess the
influence of contextual factors, participant characteristics,
and implementation such as qualitative review methods to
understand the process of implementation and its relation-
ship to effectiveness (e.g., using meta-ethnography, realist
review, or thematic analysis) [85]. When reporting the use
of these methods, authors should use the relevant, method-
specific reporting guidance to transparently report their
methods (e.g., RAMESES reporting guidelines for realist
review or the Cochrane Handbook extension on qualitative
reviews) [86,87].3.4. Results section
3.4.1. Item 18: study characteristics
Standard PRISMA item: For each study, present charac-
teristics for which data were extracted (e.g., study size,
PICOS, follow-up period) and provide the citations.
In addition, for equity-focused systematic reviews: Pre-
sent the population characteristics that relate to the equity
questions across the relevant PROGRESS-Plus or other fac-
tors of interest.
3.4.1.1. Examples. Present the population characteristics
that relate to the equity questions across the relevant
PROGRESS-Plus or other factors of interest.
B ‘‘Of the 82 studies included in this review, 55 studies
(67%) were conducted in six high-income countries:
Australia, Canada, Ireland, New Zealand, the UK,
and the USA. Forty-one of the 82 studies were con-
ducted in the USA. Twelve studies (14.6%) were
conducted in eight middle-income countries (Brazil,
China, India, Mexico, Philippines, Thailand, Turkey,
and South Africa). Fifteen trials (18.3%) were from
10 low-income countries (Bangladesh, Burkina Faso,
Ethiopia, Ghana, Iraq, Jamaica, Nepal, Pakistan,
Tanzania, and Vietnam). In 59 studies, the interven-
tion was delivered to patients based in their homes.
Five interventions were based solely in a primary care
facility.A further eight studies involved a combina-
tion of home, primary care, and community-based in-
terventions. Four studies delivered the intervention
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intervention through community meetings. For five
studies, other sites were used such as the workplace,
churches, or homeless shelters’’ [38].
B ‘‘Study participants had a mean age of 12.6 years and
were described as of American Indian descent and rep-
resenting thePueblo,Navajo,Hopi, and JicarillaApache
Indian Nations. The study setting was described as a
boarding school exclusively for American Indian youth
and promoting academic excellence’’ [88].3.4.1.2. Explanation. Approximately 50% of systematic
reviews report the effect of sex/gender on outcomes, and
less than 15% report other PROGRESS-Plus characteristics
which may be important [21,24,89]. PROGRESS-Plus in-
formation is reported in primary studies more often than
in systematic reviews [21,89]. Reporting the characteristics
of populations associated with disadvantage, if relevant to
the SR question, helps the user/reader compare their own
setting and population to those included in the studies
and can influence decision making.
It may be useful to include criteria relating to judg-
ments about which PROGRESS-Plus factors are relevant
for the review question. A number of frameworks are
available to help identify characteristics that are relevant
in describing the socioeconomic and demographic charac-
teristics of populations in addition to PROGRESS-Plus,
such as SCRAP (sex, comorbidities, race, age, and physio-
pathology) [90]; and SUPPORT Collaboration framework
[91]. There is little empirical evidence about the most effi-
cient use of these frameworks. It is unlikely to be feasible
to report all characteristics of interest, and not all charac-
teristics may be relevant for each review. It is not neces-
sary to report on all PROGRESS-Plus characteristics, as
this might encourage data dredging. However, authors
should consider which factors are relevant to their question
a priori.
Authors should report characteristics of the setting, and
whether these characteristics are entangled with the classifi-
cation of disadvantage. For example, in the systematic review
of school feeding for disadvantaged children, disadvantage
was identified by attributes of the setting such as the location
(poor, rural villages), the main occupation (e.g., subsistence
farmers) and the presence of school breakfast programs,
which were only funded and provided in very poor areas with
high malnutrition [53].3.4.2. Item 21: synthesis of results
Standard PRISMA item: Present results of each meta-
analysis done, including confidence intervals and measures
of consistency.
In addition, for equity-focused systematic reviews: Pre-
sent the results of synthesizing findings on inequities (see
item 14).3.4.2.1. Example
B ‘‘This review sought to identify studies which had re-
ported on sociodemographic characteristics known to
be important from an equity perspective. For this pro-
cess, the PROGRESS (place, race, occupation, gender,
religion, education, SES, social status) framework was
used. All studies reported the gender of participants at
baseline. Four studies reported the race of participants
and the level of education of parents. and two studies
included information about the employment status of
parents at baseline . included information on SES
of participants at baseline based on parental income
. reported some indicators related to place (the
proportion of participating schools in a rural or urban
region) and SES (the proportion of participating
schools in an urban region which were also in an area
considered to be underprivileged). When analyzing
data on outcomes, only three studies analyzed results
by any of the PROGRESS items..analyzed outcomes
by gender. analyzed outcomes by the same indicators
of place and SES that were collected at baseline (these
data are discussed previously)’’ [20].3.4.2.2. Explanation. Authors should report the results of
all analyses related to health inequities and specify which
analyses were determined a priori and which were conduct-
ed post hoc. Raw values, as well as absolute and relative ef-
fects on health inequities should be presented for the
reasons discussed previously. All analyses conducted at
the review level should be reported, even if they were lack-
ing in data or were not statistically significant.
When examining the data across a population to identify
population subgroups experiencing disadvantage, interven-
tions may have a greater absolute effect even if the relative
effect is the same. For example, a cohort of women
smokers found that the relative risk of coronary heart dis-
ease for cigarette smokers was slightly lower among
women with hypertension, hypercholesterolemia, or dia-
betes than among those without them [92]. However, the
absolute (or attributable) risk was two or more times higher
for women with those conditions. Although the relative risk
was lower, the absolute risk was much higher because the
baseline risk of coronary heart disease was so much higher
for nonsmoking women with those conditions [92].
An SOFs table is a recent requirement of Cochrane re-
views which presents the main findings of the review and
the quality of the evidence [63] and are intended for those
using the review, such as decision makers and also facilitate
the use of the review for developing guidelines and recom-
mendations [64]. The SOFs table is recommended to
include seven patient-important outcomes. To appropriately
consider equity using SOFs tables, authors should consider
three strategies: (1) include an outcome related to health
inequity to show whether the intervention enhanced health
equity (Table 2) [93]; (2) consider whether disadvantaged
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outcomes and include separate row in the SOF table to
show the absolute events for disadvantaged groups
(Table 3); [94]; and (3) Consider whether a separate SOFs
table is needed because of expected differences in relative
effects (Table 4). [95].
3.4.3. Item 23: additional analyses
Standard PRISMA item: Give results of additional ana-
lyses, if done (e.g., sensitivity or subgroup analyses,
meta-regression [see item 16]).
In addition, for equity-focused systematic reviews: Give
the results of additional synthesis approaches related to eq-
uity objectives, if done (see item 16).
3.4.3.1. Examples
B ‘‘Effect modifiers were age and SES. Younger stu-
dents had larger effects than older students and stu-
dents with lower SES had larger effects than those
with higher SES’’ [96].
B ‘‘This review used weighted regression analyses to
investigate which elements of the programs were
independently related to bullying and victimization
effect sizes. These analyses showed that the most
important elements of the program that were related
to a decrease in bullying were parent training/meet-
ings and disciplinary methods. Of all the intensity
and duration factors, the most important program el-
ements were intensity for children and parent
training/meetings’’ [97].
3.4.3.2. Explanation. The results of any additional synthe-
ses related to the equity objectives should be reported as
well as whether they were planned a priori and specified
in the review protocol. This is consistent with published
best practice in subgroup analysis [55]. Subgroup analyses
can be inappropriate, poorly specified, and prone to type I
and type II error; therefore, all subgroup analyses need toTable 2. Example of a summary of findings table that includes an outcome
The impact of user fees on access to health services in low- and middle-in
Population: Anyone using any type of health service in low- and middle-inc
Settings: Burkina Faso, Kenya, Lesotho, Papua New Guinea
Intervention: Introducing or increasing user fees
Comparison: No fees
Outcomes Relative change
in utilization
Number of
studies
Equity outcomedhealth
utilization by quartile
Not applicable 1
Lagarde and Palmer [93].be interpreted cautiously. Subgroup analyses in systematic
reviews are generally reported with insufficient detail to
judge their credibility [56].
Subgroups thatwere not identified at the protocol stagemay
be identified post hoc; however, the rationale for these analyses
should be reported. Authors should report all subgroup ana-
lyses and any analyses to assess effect modifiers such as
meta-regressiondboth statistically significant and nonsignifi-
cant to avoid outcome reporting bias of reporting only statisti-
cally significant results [98]. This may be difficult, as effect
modifiers may not be clearly reported in the primary studies.
In some cases, there may be too few studies in particular set-
tings of interest to draw conclusions. Intervention effects can
be influenced by their design and implementation as well as
the context within which it was implemented. For example,
in the school feeding review, learning outcomes such as math-
ematics achievement were found to be higher with school
meals programs, but context was important for this outcome;
if there were no teachers, then there was no change in educa-
tional achievement with feeding.
Analyses related to contextual factors should be fully re-
ported including a description of whether data were lacking
from primary studies.
3.5. Discussion section
3.5.1. Item 26: conclusions
Standard PRISMA item: Provide a general interpretation
of the results in the context of other evidence, and implica-
tions for future research.
In addition, for equity-focused systematic reviews: Pre-
sent extent and limits of applicability to disadvantaged pop-
ulations of interest and describe the evidence and logic
underlying those judgments.
3.5.1.1. Example
B ‘‘This review included studies from high-income
countries as well as lower-middle- and upper-middle-related to health inequity
come countries
ome countries
Quality of the
evidence
(GRADE)
Comments
4...
Very low
This study where quality improvements
were introduced at the same time as
user fees found an increase in
utilization for poor groups. The authors
did not report the results in a way that
the relative change in utilization could
be calculated.
Table 3. Example of a summary of findings table that includes a separate row to show the absolute events for disadvantaged groups
Vitamin A supplementation for preventing morbidity and mortality in children aged between 6 mo to 5 yr
Patient or population: Children aged between 6 mo and 5 yr
Intervention: Vitamin A supplementation
Comparison: Placebo or usual care
Outcomes Illustrative
comparative
risks (95% CI)
Relative effect
(95% CI)
No. of participants
(studies)
Quality of the
evidence
(GRADE)
Comments
Diarrhea-related
mortality
Follow-up: 48
e104 wk
Low-risk population RR 0.72; 95% CI
0.57e0.91
90,951 (seven
studies)
þþþO moderate Total number of
participants
reflects number
randomized to
studies. The
analysis combined
cumulative risk
and risk per/
1000-yr follow-
up.
3 per 1,000 2 per 1,000 (2e3)
Medium-risk population
4 per 1,000b 3 per 1,000 (2e4)
High-risk population
9 per 1,000b 6 per 1,000 (5e8)
Abbreviations: CI, confidence interval; RR, relative risk.
Imdad et al. [94].
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tries within the latter two groupings (Thailand, Brazil,
Chile, andMexico). Thismeans that, although predom-
inantly conducted within high-income settings, the
findings from this review may be generalizable to a
number of settings. A total of 19 studies specifically re-
ported incorporating strategies to target socioeconomic
and/or cultural diversity or disadvantage. One such
study was conducted outside of the high-income coun-
try setting, in Chile, an upper-middle-income country.
Of the remaining 18 studies, 7 studies conducted in the
USAwere of interventions targeting African American
children and their communities, and another two
studies targeted Native American communities. Other
studies targeted participants of lowSES, orwere imple-
mented in areas of social disadvantage. By far, themost
common setting for interventions included in this re-
view was schools (43 studies). Other interventions
were (or included) home based (14 studies),Table 4. Example of a separate summary of findings table because of expec
Summary equity impact of included studies and policies
Positiv
Increases in price/tax of tobacco products 14
Smoke freedvoluntary, regional, partial 1
Smoke freedcompulsory, national, comprehensive 2
Mass media campaigns 3
Mass media campaignsdquitlines and nicotine replacement
therapy
5
Controls on advertising, promotion, and marketing
of tobacco
2
Population-level cessation support interventions 4
Settings-based interventions (community, workplace,
hospital)
2
Multiple policies 0
Total policies 33
Total studies 31
Brown et al. [95].community based (6 studies), orwere set in a health ser-
vice (2 studies) or care setting (2 studies). Eleven
studies incorporated interventions across multiple set-
tings’’ [20].
3.5.1.2. Explanation. The conclusion should provide a
transparent assessment of the applicability, the transfer-
ability, and the generalizability of the findings to the
specific disadvantaged populations of interest (recognizing
it is impossible to make these judgments for all possible
populations). Authors should clearly report any disadvan-
taged population that was specified in the protocol and
the reasons that consideration was given to the applicability
of the results to the specified population. The applicability
of the findings of a review to disadvantaged populations
should be addressed similarly to considerations of applica-
bility to any other population [8,64,90,99,100].
Authors should specify disadvantaged populations or
settings for which the intervention is likely to be relevant.ted differences for disadvantaged population
e Neutral Negative Mixed Unclear Total
6 4 1 2 27
1 19 0 4 25
9 6 1 4 19
2 5 2 6 18
3 3 0 1 12
7 0 0 9
2 0 1 2 9
4 1 0 0 7
2 0 1 1 4
36 38 6 17 130
30 37 6 14 117
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tial impact of economic status, employment or occupation,
education, place of residence, gender, and ethnicity as po-
tential influences on the applicability of the results to disad-
vantaged populations, as well as resource or capacity
constraints, health system arrangements or baseline condi-
tions as potential reasons for there being a difference in
the potential applicability of the results to low-income
countries or disadvantaged populations. Authors should
justify any judgments about applicability using transparent
methods. There is no agreed checklist for judging applica-
bility, although many are available [81,101]. However, au-
thors should provide rationale, and any data used to make
judgments about applicability.
Applicability of results is often overlooked in systematic
reviews. For example, an assessment of systematic reviews
related to public health found that only 13% discussed
applicability [102]. The panel felt that the conclusion of
an equity-focused systematic review should provide a trans-
parent assessment of the applicability, the transferability,
and the generalizability of the findings to at least one spe-
cific disadvantaged population of interest. This population
should be prespecified in the protocol with rationale.
Authors should also specify additional disadvantaged pop-
ulations or settings for which the intervention is likely to be
relevant.
The applicability of the findings of a review to disadvan-
taged populations should be addressed similarly to consid-
erations of applicability to any other population, using
explicit methods [8,64,90,99,100]. There is no agreed
checklist for judging applicability, although many check-
lists are available [81]. Authors should provide a rationale
for the method they choose, and any data used to make
judgments about applicability, such as other evidence about
the possible impact of economic status, employment or
occupation, education, place of residence, gender, and
ethnicity, as well as resource or capacity constraints, health
system arrangements, or baseline conditions.
Item 26A: in addition, for equity-focused systematic re-
views: Provide implications for research, practice, or policy
related to equity where relevant (e.g., types of research
needed to address unanswered questions).
3.5.1.3. Examples
B ‘‘The body of evidence in this review provides some
support for the hypothesis that obesity prevention in-
terventions in children can be effective, and where
examined, have not caused adverse outcomes or
increased health inequalities. To this end, the direc-
tion of research and evaluation must move into how
to implement effectively to scale, sustain the impacts
over time, and ensure equitable outcomes. In addi-
tion, interventions need to be developed that can be
embedded into ongoing practice and operating sys-
tems, rather than implementing interventions thatare resource intensive and cannot be maintained long
term’’ [20].
B ‘‘Future research should promote the development of
effective interventions to enhance the online health lit-
eracy of consumers. Thus, there is a need for well-
designed and rigorously conducted RCTs. These RCTs
should involve diverse participants (regarding disease
status, age, socioeconomic group, and gender) to
analyze to what extent online health literacy reduces
a barrier to using the internet for health information,
or if socioeconomic group, gender, and age are more
important in influencing Internet use (Livingstone
2006). Trials should be conducted in different settings
(including low-, middle-, and high-income countries)
and should examine interventions to enhance con-
sumers online health literacy (search, appraisal, and
use of online health information) like internet training
courses’’ [103].3.5.1.4. Explanation. Implications for research, practice,
and policy should highlight the effects on equity. This sec-
tions of the review should state the research that needs to be
done to address existing knowledge gaps and should also
suggest what the unanswered research questions aredthat
is, by specifying the questions that still need answering
instead of stating that we ‘‘need more research.’’4. Discussion
We developed the PRISMA-E 2012 checklist following
guidance suggested by Moher et al. [23]. This reporting
guideline is intended to improve transparency and
completeness of reporting of equity-focused systematic re-
views. Improved reporting can lead to better judgment of
applicability by policy makers which may result in more
appropriate policies and programs and may lead to reduc-
tions in health inequities.
This explanation and elaboration document is intended
to accompany the PRISMA-E 2012 statement to improve
understanding of the reporting guideline for users [15].
The original PRISMA statement has been endorsed by
almost 200 journals; therefore, we recommend that authors
of equity-focused systematic reviews use both the PRISMA
checklist and the PRISMA-E 2012 checklist.
Potential limitations of the PRISMA-E 2012 checklist
are that certain terminology used in the reporting guideline
may not be well defined or widely used and may be defined
differently by different users. To mitigate these concerns,
we pilot tested the checklist with different groups of sys-
tematic reviews authors including those in high-income as
well as low- and middle-income countries. The results of
these pilot tests have been reported elsewhere [104].
Although some of the PRISMA-E 2012 extension items
may apply to noneequity-focused reviews, we felt that
86 V. Welch et al. / Journal of Clinical Epidemiology 70 (2016) 68e89their importance for equity-focused reviews was great
enough to warrant development of a specific reporting
guideline for these reviews. In addition, there is no planned
update of the PRISMA statement so we have included them
in this reporting guideline.
We are committed to a broad-based dissemination strat-
egy of PRISMA-E 2012 and hope to have endorsement by
all journals endorsing the PRISMA statement. Our dissem-
ination strategy includes contact with journal editors, sys-
tematic review authors and trainers, and dissemination at
meetings and conferences. We will continue to monitor
endorsement of the checklist by journal editors. We plan
to evaluate this reporting guideline at a future date to deter-
mine its impact on reporting of equity-focused systematic
reviews. We will measure the ‘‘footprint’’ of PRISMA-E
2012 by tracking the number of requests for support (e.g.,
e-mails, phone calls), and indicators of sharing of
PRISMA-E 2012 through various networks, such as Linke-
dIn, Twitter, and Facebook. We will also measure Web met-
rics, such as downloads of the Word file of the reporting
guideline checklist from our Web site.
We hope that journal endorsement and implementation, and
use by systematic reviewers will improve the reporting of
equity-focused systematic reviews. Widespread use of the
PRISMA-E 2012 checklist may increase the requests for more
data from primary researchers which may in turn improve the
reporting of equity considerations in primary research.Acknowledgments
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